Literature DB >> 18176990

Cancer-associated myositis in the presence of anti-Jo1 autoantibodies and the antisynthetase syndrome.

Dominic Legault1, John McDermott, Ana Maria Crous-Tsanaclis, Gilles Boire.   

Abstract

We describe 3 patients with inflammatory myositis in association with a neoplasm whose serum also contained anti-Jo1 antibodies, one of which presented characteristic features of the antisynthetase syndrome. No patient had a rash, and muscle biopsy was suggestive of polymyositis in all 3. Immunohistochemistry confirmed the diagnosis of polymyositis in the single patient with sufficient tissue available. Our patients remind us that the presence of antisynthetase antibodies (and even antisynthetase syndrome) in a patient with inflammatory myositis does not preclude the diagnosis of cancer-associated myositis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18176990

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  17 in total

1.  Interstitial Lung Disease in Idiopathic Inflammatory Myopathy.

Authors:  Lesley Ann Saketkoo; Dana P Ascherman; Vincent Cottin; Lisa Christopher-Stine; Sonye K Danoff; Chester V Oddis
Journal:  Curr Rheumatol Rev       Date:  2010-05

Review 2.  Myositis-related interstitial lung disease and antisynthetase syndrome.

Authors:  Joshua Solomon; Jeffrey J Swigris; Kevin K Brown
Journal:  J Bras Pneumol       Date:  2011 Jan-Feb       Impact factor: 2.624

Review 3.  Squamous cell carcinoma of the lung associated with anti-Jo1 antisynthetase syndrome: a case report and review of the literature.

Authors:  G Boleto; J-M Perotin; J-P Eschard; J-H Salmon
Journal:  Rheumatol Int       Date:  2017-04-26       Impact factor: 2.631

Review 4.  Idiopathic Inflammatory Myopathies and Malignancy: a Comprehensive Review.

Authors:  Eleni Tiniakou; Andrew L Mammen
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

5.  The Diagnosis and Treatment of Antisynthetase Syndrome.

Authors:  Leah J Witt; James J Curran; Mary E Strek
Journal:  Clin Pulm Med       Date:  2016-09

Review 6.  Malignancy in myositis.

Authors:  Zaki Abou Zahr; Alan N Baer
Journal:  Curr Rheumatol Rep       Date:  2011-06       Impact factor: 4.592

7.  Cancer-associated myositis: a 35-year retrospective study of a monocentric cohort.

Authors:  Rossella Neri; Simone Barsotti; Barsotti Simone; Valentina Iacopetti; Giacomo Iacopetti; Pasquale Pepe; Anna d'Ascanio; Antonio Gaetano Tavoni; Marta Mosca; Stefano Bombardieri
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

8.  Autoantibodies and their significance in myositis.

Authors:  Ira N Targoff
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

9.  Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.

Authors:  Eun Ha Kang; Ran Nakashima; Tsuneyo Mimori; Jinhyun Kim; Yun Jong Lee; Eun Bong Lee; Yeong Wook Song
Journal:  BMC Musculoskelet Disord       Date:  2010-09-28       Impact factor: 2.362

Review 10.  Defining cancer risk in dermatomyositis. Part II. Assessing diagnostic usefulness of myositis serology.

Authors:  V Madan; H Chinoy; C E M Griffiths; R G Cooper
Journal:  Clin Exp Dermatol       Date:  2009-07       Impact factor: 3.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.